PreludeDx Welcomes Dr. Pat Whitworth as Chief Medical Officer to Drive Expansion of Precision Diagnostics

/PRNewswire/ -- Prelude Corporation (PreludeDx®), a leader in precision diagnostics for early-stage breast cancer, announced the appointment of Dr. Pat...

Related Keywords

United States ,American ,Andrew Wade ,Pat Whitworth ,Dan Forche ,Chris Emery ,Linkedin ,Aptitude Health ,Research Committee ,University Of Louisville ,National Cancer Institute ,Prnewswire Prelude Corporation Preludedx ,National Top Doctor ,Md Anderson Cancer Center ,Facebook ,Nashville Breast Center ,University Of California San Francisco ,Instagram ,University Of Tennessee ,Prelude Corporation ,Department Of Surgery ,Chief Medical ,Breast Surgical Oncologist ,Medical Director ,Associate Professor ,National Top ,Principal Investigator ,American Society ,Breast Surgeons ,Vice Chair ,Breast Committee ,American College ,Surgeons Oncology Group ,Cancer Center ,California San Francisco ,Fjord Ventures ,Decision Score ,Know Your Risk ,Preludedx ,Health Care Amp Hospitals ,Medical Pharmaceuticals ,Biotechnology ,Personnel Announcements ,